TESARO To Present At The 20th Annual Future Leaders In The Biotech Industry Conference

WALTHAM, Mass., March 28, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and Chief Scientific Officer, will present at the 20 th Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel and Conference Center in New York City on Friday, April 5, 2013 at 1:30 p.m. EDT.

Interested parties may access a live audio webcast of the presentation via the investors section of the TESARO website, www.tesarobio.com . A replay of the webcast will be archived on the TESARO website for 14 days.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

The TESARO, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13456
CONTACT: For further information contact:                  Jennifer Davis         Senior Director, Corporate Development and Investor Relations         +1.781.325.1116         jdavis@tesarobio.com

TESARO, Inc. Logo

If you liked this article you might like

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Tesaro Stock Jumps on Sanofi, Gilead Takeover Interest

Biotech Needs a Shot in the Arm

Biotech Needs a Shot in the Arm

Market Recon: Worryingly, the Indices Seem to Be Almost Resting at Lofty Levels